The Chris Voss Show - The Chris Voss Show Podcast – Unlocking the Secrets of Cancer: IN8bio CEO William Ho, on Revolutionizing Cancer Treatment

Episode Date: August 26, 2025

Unlocking the Secrets of Cancer: IN8bio CEO William Ho, on Revolutionizing Cancer Treatment In8bio.com About the Guest(s): William Ho is the director, president, CEO, and co-founder of IN8bio, a biotechnology company focusing on immune cell technologies to combat diseases like cancer. With a career spanning nearly 24 years in the biotechnology and healthcare investment sectors, William previously served as managing partner at Aleph Point Capital and held positions with New Leaf Venture Partners. His extensive experience in venture capital and biotechnology has shaped his leadership in pioneering innovative treatments for cancer and other diseases. Episode Summary: In this engaging episode of The Chris Voss Show, host Chris Voss introduces listeners to the innovative world of biotechnology with William Ho, CEO and co-founder of IN8bio. With a keen focus on developing cutting-edge treatments using gamma delta T cells, William shares insights into his company's mission to tackle cancer's resilience by enhancing immune cell efficacy. Throughout the episode, William delves into the intricacies of gamma delta T cells and their role in combating cancer. He outlines how IN8bio's Del X platform harnesses the power of these cells to not only shrink cancerous tumors but eliminate residual cells that often cause resistance and recurrence. Highlighting the challenges and triumphs faced by biotechnology companies, he also reflects on his unique journey from Wall Street to leading a biotech firm—a path peppered with unexpected meetings and relentless pursuit for innovative solutions. Through personal anecdotes and expert insights, William underscores the importance of grit and perseverance in entrepreneurship, offering invaluable advice for aspiring biotech leaders. Key Takeaways: Gamma Delta T Cells: Innate Bio is leveraging gamma delta T cells to improve cancer treatment by targeting and eliminating residual cancer cells. Entrepreneurial Journey: William Ho shared his path from Wall Street to biotech entrepreneur, emphasizing the importance of timing and unexpected opportunities. AI in Biotech: The company is exploring how artificial intelligence can enhance drug development and clinical trial efficiency, despite current challenges with data variability. Innate Bio Success Stories: Notable clinical trial successes include patients with leukemia and glioblastoma remaining in remission after four years. Start-Up Challenges: Emphasizing resilience, William discusses the primal challenges and sacrifices entrepreneurs face, underscoring the role of grit in overcoming them. Notable Quotes: "Gamma delta T cells are a subset of our immune system. They're… white blood cells… that go out and hunt for cells that are pathogenic or are damaged or are cancerous." "Our goal is to attack the tumors when they're at their weakest early on…to try to ultimately eliminate them all." "Being an entrepreneur was much harder than I ever expected…the ability to suffer and just persevere." "If most investors knew the shit that goes wrong and how it goes wrong, they'd be terrified." "Go home, sit your wife down, and ask her, is she willing to suffer with me through this?"

You wanted the best... You've got the best podcast. The hottest podcast in the world. The Chris Voss Show, the preeminent podcast with guests so smart you may experience serious brain bleed. The CEOs, authors, thought leaders, visionaries, and motivators. Get ready, get ready. Strap yourself in. Keep your hands, arms, and legs inside the vehicle at all times.

Because you're about to go on a moment. monster education rollercoaster with your brain. Now, here's your host, Chris Voss. Hello, this Voss here from thecrisvoss Show.com. Well, you're still in there, and ladies things that makes a fish, welcome the big show. As always, the Chris Voss show, over 16 years and 24 episodes we were bringing you. All the most amazing guests, stories, journeys, lessons of life that you can share with your family and friends, so be sure to refer them.

Go to Goodrease.com, Fortress, Chris Voss, Facebook.com, dot com, 4thus, Chris Voss, LinkedIn, com for chest chris fuss chris voss one on the tick tockety opinions expressed by guests on the podcast are solely their own and do not necessarily reflect the opinions of the host or the chris fos show some guests of the show may be advertising on the podcast but it is not an endorsement or review of any kind today we're an amazing young man we're going to be talking to today about his entrepreneur founding journey and what he's built and how he's managing and leading it and all that good stuff William Hoe joins us on the show. He is the director, president, CEO, and co-founder of his company called In8 Bio.

Inate Bio, I think you just have to say it really quickly, maybe. He has worked in the biotechnology industry for nearly 24 years prior to the founding of inate bio. From 2014 to 2017, he was the founder and managing partner at a left point, capital. I'm not sure if I'm saying that right. a private health care investment fund prior to that he was at newly venture partners and a leading health care venture capitalist firm and he launched and managed the public investment and crossover portfolio served as its public investment director 2010 to 2014 welcome the show William how are you good thanks for having me Chris thanks for coming we really appreciate it

give us your dot coms where do you want people to know you guys better on the internet I apologize, I couldn't hear you, broke up for a side. Can you say that again? Give us your dot-coms, wherever people can find you on the interweb? Oh, yeah. Our website is www. n8bio.com. That's in-8bio.com.

So give us a 30,000 over you, what you do there. Yeah, N-A-Bio is a biotech company that was founded about a decade ago. It's based on the technology from my scientific co-founder and today chief scientific officer, Dr. Lawrence Lamb, he's an expert in the field of gamma delta T cells. Gamma delta T cells are a subset of our immune system. They're one of the white blood cells that are found inside our bodies that go out and hunt for cells that are pathogenic or are damaged or are cancerous and they try to eliminate all of them to prevent disease. We're the leading company today leading this technology. Dr. Lambson working with these cells for 30 years.

I've got some of my coffee right now. I have it every morning. Sprinkle some in there. And so this company, the hope is to get these, to be able to maybe activate this technology more and kill cancer? The hope is to use these cells to go hunt any residual cancer cells or to treat pathogenical blood cells that might result in autoimmune diseases in some cases. Ultimately, we can treat cancers. We can shrink cancers. But the problem is as we treat these tumors, you're training the tumors to become stronger and stronger. There's always residual tumor cells, whether they're microscopic and they can't be seen

or they're resistant to the current therapies, all it ultimately takes is one cell that doubles, and over time, patients eventually relapse or progress. Our goal is, can we use these cells to hunt out the residual cells? Because if we can eliminate them, what we call achieving cancer zero, then we can prevent patients from relapsing or progress. I mean, that's what the doctors have always told me,

like with my dogs, I have cancer. They're like, Chris, even if we beat it, it will come back and I'll come back stronger. And so is that why? Absolutely. Resistance? Absolutely. It's like fighting, right? The more you fight, the more you train, the stronger you get.

The more different therapies, we apply to different cancers, you're selecting for tumor cells that get stronger and stronger. After a couple lines of therapy, it becomes very difficult to beat. And so our goal is to attack the tumors when they're at their weakest early on to try to ultimately eliminate them all. Yeah, because I'm no scientist, so don't quote me, folks. But my understanding is that's where cancer forms cells get damaged or misaligned or malformed or, you know, some sort of issue with them. They just go out drinking on Friday nights and they partied way too hard. That's basically it, folks.

And they've, they're done. they're there you know it's time to move on and is that correct is am i kind of well we get damaged our cells are damaged every single day i'm in new york city when i go outside in sunshine we get damage when we go drinking you know bourbons on friday night you get damage from the alcohol you know everything in our lives drives dna damage The fact is we have powerful biology inside our bodies that help try to fix that damage. It's called the DNA damage response pathway. So our bodies, they learn to fix it.

They either fix the damage, they drive the cells that have damage to commit suicide or our main systems identify those cells and eat them up and to eliminate them. Yeah, eat the bad cells, and can you get this to eat some fat, too? I need these sentries to go hunt down my fat cells and eat them too. That would be great if we could work that out. But you guys have something called the Deltex platform. Tell us about what that is and what that includes. Yeah, Deltex is just the trade name we've given to our technology and our platform. It encompasses all of our know-how, our capabilities.

to manipulate, expand, and grow these gamma-delta T cells. They're powerful cells that have been found to be associated with better survival when they are present in your bodies at higher levels. Oh, are they usually present in our body at higher levels when we're young and maybe they fade away when we get old? In actuality, when a person is born, they're the first cells that actually exist. Really? Yeah.

These cells are pretty unique in that they form a major role on discriminating what is safe and should be left alone versus what is dangerous and should be killed. Our bodies, our immune systems or our white blood cells are consists of two major components. One, the early attackers, what we call innate, which is how we came up with the company name, innate. It's a play on the innate immune cells and the adaptive or the long-term memory. The fact is when you're born, you have no memory. You haven't seen any infections. You haven't built any immune response. And so these gamma-delta's when an infant is first born,

they encompass a major part of our immune system. Wow. And so do they fade as we grow older? Is that why we start breaking down when we get old? I think, unfortunately, as all of us get older, all of our immune cells get weaker and weaker. We find that we do have less of them. They are less powerful. They're not as strong as we get older.

Unfortunately, as we've built our Deltex platform, the one predictor of outcomes and the strength of the cells ultimately is the age of the patient or of the donor, a 20-year-old cells. are much more potent than that of a 67 or 80-year-old. Note to self, start eating 20-year-olds for breakfast. The, and this is in, folks, don't grow old, according to the newest science. I'm fighting it every step of the way. What is that? Don't go into that good night without a fight, something like that.

So you guys, and you guys also work with drug resistance immunotherapy. So you guys are coming up with technology that can, deal with drug-resistant stuff. The fact is, as we treat, for over 80 to 90 years, the standard of care for most cancer indications is some combination of surgical resection, followed by chemotherapy and radiation. The surgeon can remove the bulk of a tumor with his or her knife.

And then when we treat with chemo, yeah, we can shrink the tumor, but the problem is chemotherapy harms our own immune cells. It kills our immune cells. Patrick Sunsham, who is one of the most successful entrepreneurs in biotech, has recently been talking about his therapy that they're developing called BioShield, where they're trying to protect the immune cells. Put a condo over the immune cells?

That's more of what we're trying to do. He's trying to grow more. I guess what we try to do is... You can get Trojan as your sponsor or something. Yeah. What we've done is we've actually protected our immune cells from being killed by the chemotherapy. And the way we do that is we found the tumor's own resistance mechanism to the chemotherapies and we hijacked it. We genetically engineered it directly into our immune cells so that they'll survive.

combined dosing. So we protect them so that they remain functional. They can go out and seek any cells that are left through the chemotherapy. I have this, when you say seek the cells, I think of those, the movie The Matrix, you know, those big octopus things that would go hunt you down and kill you. That'd be kind of cool. Is there any way, can I get this in pill form, these gamma things? No, they're cells.

So we actually have to take them out of the blood of individuals or from donors, and we manipulate them, we genetically engineer them and grow them up so that you have more soldiers. All right. Note to self, go back to eating 20-year-olds. Jeffrey Dahmer. Don't do that, folks. It's just a joke. Don't start a call over it. So, yeah, I mean, this is really interesting. So tell us about yourself. How did you found this company? And what were some of your entrepreneurial influences you were growing up? What got you? you into this sort of fields you know i actually never wanted to be a CEO nor an entrepreneur i found myself in this position somewhat by accident i went to college i'm originally canadian american now went to college in canada studied biochemistry didn't know what i want to do ended up getting an

NBA and then coming to new york city and working on wall street i spent 17 years on wall street I started my career in investment banking. I was eventually an equity research analyst, was the lead biotech analyst for Bank of America, was recruited to investment fund, one of the leading healthcare VC funds at the time and started running their public portfolio and late stage private,

what today they call crossovers, ran that for four years. In 2014, I decided to start an investment fund, now defunct, quite frankly, I couldn't raise any money. Nobody believed in our thesis at that time I was working with someone. And we had built algorithms. At the time, we were scraping what we called unstructured data sets so we can scrape websites and we're using algorithms and what we called natural language processing to look for patterns that could be used for investing. And funny thing, 2014, everybody said, are you crazy? You can't scrape websites and use algorithms to process and look for data. And a little bit ahead of our time too early. But through

those processes, I was looking for technology that could take what came out, what was originally known as chimeric antigen receptor T cells or CART. CART, now it's been about 15. years in 2014 the technology was quite nascent we could take blood out of individuals genetically engineer the white blood cells to target cancer specifically and then send them back in through an infusion to hunt down tumor cells worked wonderfully in the blood cancers today 15 years later some of the earliest patients remain alive and in remission and i was trying to figure out how do you go from the leukemias and lymphomas to the solid tumors. Yeah.

The pancreatic, pancreatic cancer, liver cancer, lung cancer, brain cancer. And I somewhat fortuitously met my scientific founder because he got stuck in New York City in a snowstorm. So Dr. Lamb had worked. Snowstorm. He met in a snowstorm? We met in a snowstorm. It was what was January 21st, 21st, two. 2015, the

East Coast was pounded by snowstorms. Boston had seven foot snowdrift. Wow. And in one of those storms, one of his colleagues that I had met at a conference called me and said, hey, the guy I told you about, he's in New York City, his flight got

canceled. The city is shut down. Would you like to meet him? So I said, sure, why not? And I took him out for lunch. That's awesome. That's awesome. That's awesome. What a wait? And so, right away, do you guys know, you've got out of the ideas? No, I spent, you know, we spent three hours at a restaurant just talking about his life's work.

And I thought, who is this crazy guy with a southern accent out of Alabama? And what's he talking about? I'd never even heard of these cells, the gamma-dilta-t cells that we work on today. But I went home and started pulling papers and started reading, calling him, emailing him, asking him questions. and, you know, three months later, I looked to myself and said, shit, I think this works. Ah. I said, what are you doing with it?

He said, I don't know. At the time, Dr. Lamb was a professor of medicine at the University of Alabama at Birmingham. And he was a director of the GMP manufacturing facility and a clinical immunologist. And I decided to license the technology and launch the company. It's been almost 10 years. What a crazy world. So what's the future hold? I mean, does AI have a future impact here that can help you guys do what you guys are doing there?

I think we're still trying to figure out how to use AI. Yeah. You know, we use AI for the day-to-day. A lot of day-to-day items for diligence and research. You know, we discovered you can get in 30 seconds what used to take two months of consulting work and get a decent answer. But we're still trying to figure out how to use it towards drug development, understanding biology, and getting our clinical trials to move faster. This should be amazing stuff if we can get at technology. There's so many people chasing this.

I'm hoping, you know, somebody gets it or a bunch of people get it. You know, there's some, the challenge if you, to go back to the, when I started the fund that was trying to be based on what today, I guess, could be called AI. On the tech side, there's always the challenge of data and how clean is the data, right? There's an old mantra, garbage in, garbage out. And so how do you clean the data? How do you make sure your data is robust? And the challenge quite often is in medicine and in biotechnology, we deal with humans. and all the vagaries and variability that occurs with people.

You design clinical trials where we say we're going to take blood samples, for example, on day 0, 7, 30, 60, 180, 365, invariably day 60 is Thanksgiving, and the patient, even if they have cancer, is not coming in, right? They want to spend that time with their family, and so you have variabilities. And those are things we're trying to figure out how you deal with. bio technology side. Yeah. It's too bad we can't come up with some of these gamma T cells that can hunt down stupidity.

I've got like a whole network over on Twitter that you guys can just make billions off of. You know, if we can hunt down. What's the old line from George Carlin? So anyway, anything more we want to talk about before we go out and your company is what you do it and how you lead them? No, look, it's been a tough five years in biotech. As I said, we've been doing this for more than 10 years. We're quite proud. We had an oral presentation at the largest oncology conference every single year.

Globally, it's called the American Society of Clinical Oncology. We're one of a handful that were picked for an oral presentation this past June. And we're excited. We have a patient with a grade four glublastoma who's four years out and still progression-free. Wow. Yeah. So you guys are seeing successful results from the work then? We believe so.

We have two main trials, one in leukemia focused on acute myeloid leukemia or AML patients, a horrible disease, another trial in glioblastoma, both of them with patients four years out having remained in remission. That would be great, too, if you could use it in animals, because I lost my dog last year to leukemia. And just, it's a horrible thing to deal with. you know all these things are you know it's kind of funny it's we we don't have these things fixed yet i think what was it 2001 space odyssey we were supposed to like have this interesting life we did get iPads we didn't get iPads yeah the uh styrofoam boxes for the ozone layer steal the line from Neil Young's

Keep ira rocking in the USA what do you what do you try and do as a co-ceo i think it was were you co-ceo or co-founder co-founder co-founder co-founder as a CEO what sort of uh what sort of style of leadership do you try and utilize or culture that you try to engender in your company you know i'm a very direct CEO um i'm one who believes in leading from the front i think I don't put my team through anything that I'm not willing to do myself. I think I've been

in various organizations from massive international banks, global banks, to small funds, to small biotech companies. And I think you know,

people want to be treated fairly. They, they, the worst thing for a culture is, when people see others who aren't working so hard or are, you know, hiding things, but still getting credit for things that they don't do. So nothing pisses off people more than that. Even working, you know, 50, 60, 70 hours a week doesn't piss people off like that.

Yeah. They want to be recognized. They want to get the credit. but they want to I'm direct with my people yeah yeah well that's really good you know it's if people need to know what the CEO wants what he stands for what he's about and all that good stuff you know they don't want to be left in the dark does this guy really care about us does he is he what is he really up to is he communicating do we even know what the fuck he wants you know all these things are really important and a lot of CEOs really need to

think about their culture What sort of advice would you give to upcoming entrepreneurs, up-and-coming entrepreneurs? You know, we talked about this before we started a little bit. You know, people often ask me, you know, what's the secret? What's the, you know, what can you tell me? And really, beyond all the skills you may have and all the knowledge, being an entrepreneur was much harder than I ever expected. quite frankly most people would probably not do it except for ignorance and naivete going into it and i think the biggest strength someone could have is probably just grit and ability to suffer

and just persevere i mean you started this show you're an entrepreneur yeah i mean i never shut up so it just worked for me as a venue. I'll tell you a little story. I had someone came to me. He was a hedge fund manager, someone I had known for years. He was a portfolio manager at one of the big pod shops. And he came to me and said,

I have an asset. And can you give me some advice? Can we grab lunch and can you give me some advice? I said, sure, let's go grab lunch and I'll give you some advice. So I take him out to lunch here in Midtown in New York. And we sit down and goes, okay, what can you tell me? what advice will you give me to start what should i do to start the company and i said go home sit your wife down and ask her is she willing to suffer with me through this and is she ready

not to be a hedge fund manager's wife anymore and he goes what what are you talking about no what lawyers do i use what do i do i said look none of that is going to drive your success but you are going to suffer and you know you're you're going to have to cut back on your expenses she's willing to have a certain lifestyle are you willing to cut back on that and is she going to stick with you through that suffering because otherwise you're either going to no longer be an entrepreneur or you're going to be divorced and that's quite true for a lot of starting a lot of companies you know it really is I started my first company I was 18 and I've owned companies on my life and I'm always starting new companies and sadly with 2008 it wiped out a bunch of my

stuff so my biggest jewel was a in my empire was a mortgage company of all things to have in 2008 but yeah there's a lot of suffrage I laugh at that but it might be the most true statement of entrepreneurialism the ability to suffer you know when we started our companies we we started two multi-millionaire companies within a year and a half each other. The first one we started with $2,000, the second we started with $4,000 and we built those and they were profitable in three months. We built them in a multimillionar companies that lasted up to 20 years and had been for 2008. Probably would have been here now. But, you know, the start of those companies was a lot of sweat equity. It was 18-hour days, four hours of sleep. Thank God we

were all. We were really young. I told my business partner, I go, you know, If we're going to do this, we've got two choices in life. We've got two pathways. We can either do this corporate shit we've been doing, and we can work for the man for 40 years and maybe leave with a golden parachute if we get into echelons of management. If we were two stupid kids who didn't go to high school or didn't go to college either. So I said, but I got to tell you, all these people I see like retiring, you know, getting golden parachutes of 40 and 50 and going start in the companies.

They seem a little old and tired, and I'm not sure I'm going to have the energy at 40 and 50 to start it, to start my first venture. I go, or we can do it now. Well, we've got all this gumption, all this collagen, and all this ability to lose sleep and live on ramen for fucking four days. The, you know, I think now's the time. And so we did it. And it was a lot of suffrage.

It was a lot of sweat equity. It was a lot of sleepless nights. and living on coffee and living on the road. Probably didn't take the best of care and health considering, but, you know, back then, people weren't worried about health, I guess. And so it was just about the grind. And, you know, I mean, my body's paid for it.

I mean, it's part of one of the suffrage. But I think you're right. It's a lot of suffrage and a lot of problem solving. It will grow you in ways that nothing else will, other than maybe being a parent. I think being a parent will change people and have an impact of them more. It might have more of an impact than, because I think my friends who have babies, they lose more sleep than I did the first few years of our company.

But, you know, so other than parenting, but I don't think, I don't think the problem with parenting is it doesn't self-actualize you and self-accountability you as being a CEO of your own company and doing a startup. I've never been a parent, so you can send me emails if you want. for some of the parents I've seen that have no lack of self-accountability. I think I can prove that point. I've seen your children. I've dated your children and they're awful, especially that Gen Z. So, you know, it makes you grow up in a lot of ways. I mean, unless you have a lot of money and your daddy gave it to you and you can just run around and start companies,

if you've started them from the ground up and blood, sweat, and tears, you know, there's no one you can turn to. You can't half-asset. you know the thing about a company is if you fucking fuck around you're going to find out and fail you know you know you can you can you can fuck up a kid's head and he's still walking around me look at me anyway you can you could do everything right and still fail exactly true you about my first entrepreneur venture is a fund you know today in 2025 uh you talk about you know AI and scraping websites and using algorithms to look for patterns and you're like, of course you can fucking do that.

In 2014, people look like, you know, are you crazy? It can't be done. You're way ahead of your time on that one. Yeah, it's, I think it's, I think everyone should dry it once. But, you know, that's why anytime I see one of those lemonade stands or I see Girl Scouts or Boy Scouts selling stuff, they don't do it so much anymore. In fact, I haven't seen one for a while. But usually they'll be out in front of stores and stuff.

selling their wares and i have a habit uh i talked about this in my book i have a habit of if if one of these young people will hit me up for money i'll i'll buy a few boxes of them and and tell them you know go be an entrepreneur uh and try and see that sort of sort of mindset because people were good to me when i was young not all people were good to me when i was young selling a boy scout was a scoutorama shit but uh you know it's this is some we need to do. I think we need to teach entrepreneurism in school. You know, at least have a class on it.

They can just call it the class of suffrage. I think they used to call that gym. That's true. That's actually true. You know, I'll give a little story. You know, when we were early on in the first days and we were desperate for cash and I had a massive deadline to raise cash. Because you talked about having kids.

So I've got two kids. My daughter at that point was. You sold one of the kids for a guy? My daughter was probably six months. So I did both. I was doing both around the same time. Wow. And my daughter was six months.

And we're trying to close some money because I was almost out of money. And it's the middle. Oh, I at one time did put my house up for collateral of my apartment to, yeah, My wife was sideways on the couch with the migraine because we agreed to colonelize our apartment to get cash to get through. But we were trying to close this financing. My wife goes to bed. I'm working on the deal docks 11 o'clock at night. I'm working with the lawyers.

I hear pitter pitter pitter peter and slap. And I was like, what just happened? I walk around the corner and my daughter had gotten out of bed I guess she was a little older because she was walking and she was trying to get to the bathroom and vomited all over the floor

and so I took her to the bath cleaned her up, clean the walls off, clean the floor off, put her back to bed and then back to doing the little dogs in the middle of the night people always ask you like how many, why do you have so much time Chris for so many projects. I'm like, I don't have a wife

and kids. I can get so many. I'm always adventuring and doing stuff and starting new companies and people are like, how do you have so much time on your hands? And I'm like, I don't have a wife of kids. I mean, but that's, I mean, that's the challenge. That's just part of the gear. That's part of the suffrage. Most people have kids

and you guys are, if you start a company, you're going to have to balance that out between the two. But, you know, it really speaks to you know, we talked about this on the show and this has kind of become a theme as of late when we talk about these items is really it's it's a job of problem solving like I think they need to rename entrepreneurial and call it problem solver well that or chief sufferer

maybe chief sufferer is good I'm considering that now when I was on wall street someone recently asked me what do you think about being Wall Street versus being an operator and and I said you know, when I was on Wall Street, I had no clue what it took to keep the proverbial wheels on the bus just going straight. If most investors knew the shit that goes wrong and how it goes wrong, they'd be terrified, right? Like, you come in one day and you're like, how the fuck did that happen? It's like, well, I just can't go fix that. That's my job. Yeah, Bob. Bob stuck a tool in the machine. You know, it's on fire.

You know, that's sort of shit where you're just like, really? Like I needed this today. Yeah. But so great stories from the entrepreneurial journey. So, you know, I'm thinking I'm going to change my title on my business card to CEO and Chief Suffer. So at least I can play the victim for a change or whatever. Anyway, thanks for coming on the show. Give us your dot com so people can find you on the.

interwebs. Yeah, it's www. dot inatebio.com. That's www. I.N. the number 8bio.com. Thank you very much for coming to the show. We really appreciate it, William.

Thank you. Thanks for having me today. Thank you. And great discussion. Thanks for honest for tuning in. Go to Goodrease.com, Fortress, Chris Foss. LinkedIn.com.

Fortress, Chris Foss, one, the TikTok. It all is a crazy place in it. If you go to each other, stay safe. see you guys next time. And that should have us out.